544.28MMarket Cap-5713P/E (TTM)
10.300High8.822Low1.07MVolume8.920Open8.830Pre Close10.53MTurnover2.98%Turnover RatioLossP/E (Static)53.52MShares30.99052wk High2.38P/B364.65MFloat Cap5.67052wk Low--Dividend TTM35.86MShs Float72.200Historical High--Div YieldTTM16.74%Amplitude2.190Historical Low9.854Avg Price1Lot Size
EyePoint Pharmaceuticals Stock Forum
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals (EYPT.US)$
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
📊⚡️📊
No comment yet